Joan-Carles Arce
Overview
Explore the profile of Joan-Carles Arce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
798
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nelson S, Fauser B, Garcia-Velasco J, Klein B, Arce J
Fertil Steril
. 2024 Jan;
121(4):707.
PMID: 38266801
No abstract available.
2.
Ishihara O, Nelson S, Arce J
Reprod Biomed Online
. 2021 Nov;
44(1):177-184.
PMID: 34799275
Research Question: Is ovarian response associated with individualized follitropin delta dosing regimen comparable across different ethnic populations? Design: Post-hoc analysis of ovarian response in 800 IVF/intracytoplasmic sperm injection (ICSI) patients...
3.
Havelock J, Henningsen A, Mannaerts B, Arce J
J Assist Reprod Genet
. 2021 Jul;
38(10):2651-2661.
PMID: 34254211
Purpose: To describe the pregnancy and neonatal outcomes using fresh and vitrified/warmed blastocysts obtained from ovarian stimulation with follitropin delta in controlled trials versus follitropin alfa. Methods: This investigation evaluated...
4.
Qiao J, Zhang Y, Liang X, Ho T, Huang H, Kim S, et al.
Hum Reprod
. 2021 Jun;
36(9):2452-2462.
PMID: 34179971
Study Question: Is ovarian stimulation with follitropin delta in its individualised fixed-dose regimen at least as efficacious as follitropin alfa in a conventional dosing regimen in Asian population? Summary Answer:...
5.
Ishihara O, Arce J
Reprod Biomed Online
. 2021 Mar;
42(5):909-918.
PMID: 33722477
Research Question: This study aimed to establish the efficacy and safety of ovarian stimulation with a follitropin delta individualized fixed-dose regimen based on serum anti-Müllerian hormone (AMH) concentration and body...
6.
Pellicer N, Galliano D, Herraiz S, Bagger Y, Arce J, Pellicer A
Hum Reprod
. 2020 Dec;
36(4):850-858.
PMID: 33355352
Endometriosis requires medical management during a woman's reproductive years. Most treatments aim to create a hypoestrogenic milieu, but for patients wishing to conceive, drugs that allow normal ovarian function are...
7.
Ishihara O, Klein B, Arce J
Fertil Steril
. 2020 Dec;
115(6):1478-1486.
PMID: 33272623
Objective: To establish the relationship between follitropin delta doses (recombinant follicle-stimulating hormone produced from the human cell line PER.C6) and ovarian response in Japanese women undergoing in vitro fertilization/intracytoplasmic sperm...
8.
Arce J, Larsson P, Garcia-Velasco J
Reprod Biomed Online
. 2020 Aug;
41(4):616-622.
PMID: 32819842
Research Question: The objective of this investigation was to determine the daily follitropin delta dose (µg) providing a similar ovarian response to 150 IU/day follitropin alfa. Design: The study was...
9.
Sperm DNA Methylation Epimutation Biomarkers for Male Infertility and FSH Therapeutic Responsiveness
Lujan S, Caroppo E, Niederberger C, Arce J, Sadler-Riggleman I, Beck D, et al.
Sci Rep
. 2019 Nov;
9(1):16786.
PMID: 31727924
Male factor infertility is increasing and recognized as playing a key role in reproductive health and disease. The current primary diagnostic approach is to assess sperm quality associated with reduced...
10.
Fernandez-Sanchez M, Visnova H, Yuzpe A, Klein B, Mannaerts B, Arce J
Reprod Biomed Online
. 2019 Feb;
38(4):528-537.
PMID: 30713022
Research Question: Is individualization of dosing with follitropin delta in sequential ovarian stimulation cycles an effective preventive strategy for ovarian hyperstimulation syndrome risk? If so, for which patients does an...